10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,401 | -13,470 | -43,544 | -27,292 | 180 |
| Depreciation Amortization | 23,590 | 9,957 | 43,816 | 32,530 | 19,465 |
| Income taxes - deferred | -1,434 | N/A | N/A | N/A | N/A |
| Accounts receivable | -534 | 7,980 | 41,314 | 44,546 | 37,917 |
| Accounts payable and accrued liabilities | 8,072 | 4,782 | -2,126 | 3,292 | 3,488 |
| Other Working Capital | 1,231 | 5,288 | 24,250 | 6,361 | -25,409 |
| Other Operating Activity | 43,570 | 11,583 | 72,340 | 35,836 | 16,418 |
| Operating Cash Flow | $43,094 | $26,120 | $136,050 | $95,273 | $52,059 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 240 | 286 | 1,765 | 1,141 | 639 |
| PPE Investments | -3,185 | -1,597 | -5,935 | -4,158 | -3,471 |
| Net Acquisitions | -6,101 | N/A | -9,268 | -8,616 | N/A |
| Investing Cash Flow | $-9,046 | $-1,311 | $-13,438 | $-11,633 | $-2,832 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,289 | 273 | 6,803 | 4,561 | 3,944 |
| Other Financing Activity | -8,690 | -8,690 | 0 | 0 | 0 |
| Financing Cash Flow | $-5,401 | $-8,417 | $6,803 | $4,561 | $3,944 |
| Exchange Rate Effect | -101 | -73 | 484 | 441 | 474 |
| Beginning Cash Position | 473,966 | 473,966 | 344,067 | 344,067 | 344,067 |
| End Cash Position | 502,512 | 490,285 | 473,966 | 432,709 | 397,712 |
| Net Cash Flow | $28,546 | $16,319 | $129,899 | $88,642 | $53,645 |
| Free Cash Flow | |||||
| Operating Cash Flow | 43,094 | 26,120 | 136,050 | 95,273 | 52,059 |
| Capital Expenditure | -3,185 | -1,597 | -5,935 | -4,158 | -3,471 |
| Free Cash Flow | 39,909 | 24,523 | 130,115 | 91,115 | 48,588 |